bioRxivMicrobiologyPreprint
Excessive sample reagent incubation time increases the risk of false rifampin resistance results in Xpert(R) MTB/RIF Ultra tests performed on paucibacillary Mycobacterium tuberculosis sputum.
Gayatri Shankar ChilambiiD, Kunj Modi, Paulami RudraiD, Yiwang CheniD, Soumitesh ChakravortyiD, David AllandiD
Abstract
A high rate of false rifampicin resistance (RIF-R) was recently reported in paucibacillary sputum samples tested with the Xpert(R) MTB/RIF Ultra (Ultra) assay. However, 96% of the studied facilities started the test 8 - 12 hours after addition of sample reagent (SR), exceeding the manufacturers recommended limit of 4 hours. Assessed whether excessive long SR incubation could lead to similar false RIF-R results in paucibacillary samples in a reference laboratory setting. We evaluated the performance of the Ultra assay following incubation of TB-negative sputum spiked with 300 CFU/mL and 100,000 CFU/mL levels of Mycobacterium tuberculosis (Mtb) H37Rv in SR for different durations (15 min to 24hrs.) at different temperatures (-20 to 370C) to determine the effect on RIF result calls. No false RIF-R results were observed in these samples with 105 CFU/mL Mtb at any of the conditions tested, even when they deviated largely from recommended limits. Similarly, freezing the 300 CFU/mL SR treated samples at minus 200C for 18 h also prevented the development of false RIF-R results. However, sputum spiked with 300 CFU/ml Mtb, produced false RIF-R calls at longer incubation times and higher incubation temperatures than are recommended by the manufacturer. Approximately half of the results displayed melt patterns consistent with hetero-resistance, indicating SR-induced mutagenesis in a wild-type background. This study demonstrates that extended off-label SR incubation of paucibacillary specimens beyond the recommended 4-hour limit can generate false RIF-R results. Freezing paucibacillary specimens in SR may mitigate this risk although it is not yet an approved procedure.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Xpert Ultra can unambiguously identify specific rifampicin resistance-conferring mutations
K. C. S. Ng, A. van Deun, … B. C. de Jong·bioRxiv·May 9, 2018
- High-resolution melt curve analysis for rapid detection of rifampicin resistance in mycobacterium tuberculosis: A single-center study in Iran
S. Arefzadeh, M. J. Nasiri, … M. Alahyar·bioRxiv·Sep 9, 2019
- How well do routine molecular diagnostics detect rifampicin heteroresistance in Mycobacterium tuberculosis?
K. C. S. Ng, P. Supply, … L. Rigouts·bioRxiv·Aug 8, 2019
- Detection of rifampicin resistance in sputum samples by PCR-ELISA
Rosa Bellido-Pantoja, Edson Pacheco, … Omar Cáceres·bioRxiv·Sep 19, 2022
- Most-probable number based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical M. tuberculosis isolates
S. Vijay, H. N. Nhung, … N. T. T. Thuong·Antimicrobial Agents and ChemotherapyPeer-reviewed·Feb 17, 2021
- Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum.
Y. Cao, H. Parmar, … S. Chakravorty·bioRxiv·Sep 8, 2020